Development and validation of a perioperative risk prediction model for pressure ulcers in neurosurgical procedures: a machine learning approach with protocol compliance metrics.
{"title":"Development and validation of a perioperative risk prediction model for pressure ulcers in neurosurgical procedures: a machine learning approach with protocol compliance metrics.","authors":"Yaping Wang, Weiguang Yu, Hui Zhi, Kun Shang, Hongmei Yin, Dandan Shan, Xiao Li, Wenxia Li, Xiuru Zhang, Baoli Zhang","doi":"10.3389/fmed.2025.1600481","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study aimed to develop and validate a nomogram for predicting pressure ulcer (PU) incidence in neurosurgical patients to enhance postoperative risk management.</p><p><strong>Methods: </strong>A retrospective analysis of 1,020 patients across four tertiary centers (2005-2025) evaluated 20 variables. Propensity score matching (PSM) addressed confounding, while LASSO regression and machine learning identified predictors. Model performance was assessed via AUC-ROC, C-index, and decision curve analysis.</p><p><strong>Results: </strong>Eight independent predictors of PU were identified: diabetes duration, BMI, albumin, prealbumin, age, hemoglobin, temperature difference, and urinary incontinence. The training set achieved an AUC-ROC of 0.825 (95% CI: 0.797-0.853) with 77% sensitivity and 92% specificity, while the validation set showed an AUC-ROC of 0.800 (95% CI: 0.753-0.847) with 76% sensitivity and 92% specificity. The nomogram demonstrated recalibrated C-indices of 0.833 (training) and 0.826 (validation). Decision curve analysis confirmed significant net benefit across clinical thresholds.</p><p><strong>Conclusion: </strong>This validated nomogram enables early PU risk stratification, facilitating personalized postoperative interventions. Given its high sensitivity and specificity, the model can be integrated into clinical practice to assist in early identification of high-risk patients, thereby improving patient outcomes through timely interventions.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1600481"},"PeriodicalIF":3.1000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12263567/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1600481","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: This study aimed to develop and validate a nomogram for predicting pressure ulcer (PU) incidence in neurosurgical patients to enhance postoperative risk management.
Methods: A retrospective analysis of 1,020 patients across four tertiary centers (2005-2025) evaluated 20 variables. Propensity score matching (PSM) addressed confounding, while LASSO regression and machine learning identified predictors. Model performance was assessed via AUC-ROC, C-index, and decision curve analysis.
Results: Eight independent predictors of PU were identified: diabetes duration, BMI, albumin, prealbumin, age, hemoglobin, temperature difference, and urinary incontinence. The training set achieved an AUC-ROC of 0.825 (95% CI: 0.797-0.853) with 77% sensitivity and 92% specificity, while the validation set showed an AUC-ROC of 0.800 (95% CI: 0.753-0.847) with 76% sensitivity and 92% specificity. The nomogram demonstrated recalibrated C-indices of 0.833 (training) and 0.826 (validation). Decision curve analysis confirmed significant net benefit across clinical thresholds.
Conclusion: This validated nomogram enables early PU risk stratification, facilitating personalized postoperative interventions. Given its high sensitivity and specificity, the model can be integrated into clinical practice to assist in early identification of high-risk patients, thereby improving patient outcomes through timely interventions.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world